Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
EBCC-12 European Breast Cancer Conference
2 - 3 Oct 2020
Virtual, Global
Highlights from EBCC-12
Prof Nadia Harbeck - EBCC Conference Chair
23 Oct 2020
Overview of the MINDACT trial results presented at EBCC-12
Prof Etienne Brain - EORTC Breast cancer group chair
16 Oct 2020
EBCC-12 during COVID-19
Prof Etienne Brain - EORTC Breast cancer group chair
16 Oct 2020
Why don’t all European breast cancer patients get the most appropriate care?
Prof Philip Poortmans - Antwerp University, Antwerp, Belgium
15 Oct 2020
The management of endocrine therapy in young patients with breast cancer
Dr Olivia Pagani - European School of Oncology, Milan, Italy
8 Oct 2020
Determinants of non-participation in population-based breast cancer screening: a...
Lilu Ding - University of Groningen, Groningen, Netherlands
8 Oct 2020
Neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer
Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
6 Oct 2020
Actionable pathogenic variant detection in breast cancer genes
Prof Gareth Evans - The Central Manchester NHS Foundation Trust, Manchester, UK
6 Oct 2020
Prediction of hot flushes in women taking tamoxifen for breast cancer prevention
Michael Hale - Queen Mary University, London, UK
5 Oct 2020
The impact of COVID-19 on breast cancer screening, treatment, research and meeti...
Prof David Cameron - Representative EBC Council
5 Oct 2020
Improved decision making for older women with early breast cancer
Prof Lynda Wyld - University of Sheffield, Sheffield, UK
2 Oct 2020
MINDACT: 70-gene signature test as guidance for breast cancer treatment
Josephine Lopes Cardozo - Netherlands Cancer Institute, Amsterdam, The Netherlan...
1 Oct 2020
